Compare GoPro Inc (GPRO) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs Zoetis Inc — how do they compare? GoPro Inc trades at $1.19 (market cap $243.50M), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 124× GoPro Inc's market cap, and Zoetis Inc pays a 2.9% dividend while GoPro Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GoPro Inc for 45 Days and Zoetis Inc for 70 Days on average.
| GPRO | ZTS | |
|---|---|---|
Market Cap | $243.50M | $30.20B |
Volume | 11,527,160 | 6,175,327 |
Sector | Technology | Health |
52-Week High | $2.35 | $147.53 |
52-Week Low | $0.58 | $69.09 |
Typical Hold Time | 45 Days | 70 Days |
Enterprise Value | $302.28M | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $1.18, down 3.28% today, amid volatile trading following a recent merger announcement with Starman Optical. The company faces fundamental challenges with negative net income margins (-28.52%) and declining revenue, though valuation ratios appear low with P/E of 4.56 and P/S of 0.34. Technical indicators show a bullish overall signal with RSI at oversold levels, while analyst sentiment remains mixed with only 21% recommending Buy.
The proposed $285 million merger offers potential upside from current levels, but significant execution risks and ongoing cash burn (-$53M net cash flow) create substantial uncertainty. Investors face binary outcomes between merger completion benefits and continued operational struggles in a competitive camera market.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
